Effect of long term administration of resveratrol on lipid concentration in selected organs and liver's histology in rats fed high fructose diet

Journal of Functional Foods

Volumn 5, Issue 1, 2013, Pages 299-305

  Kopeć, Aneta ^a   Piatkowska, Ewa ^a   Leszczyńska, Teresa ^a   Koronowicz, Aneta ^a  

^a UNIVERSITY OF AGRICULTURE IN KRAKOW   (Poland)

Author keywords

High fructose diet; Lipids; Liver; Rats; Resveratrol

Indexed keywords

ANIMALIA; RATTUS; RICE STRIPE VIRUS;

EID: 84873260792     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2012.10.020     Document Type: Article

References (32)

1. Ahn J., Cho I., Kim S., Kwon D., Ha T. Dietary resveratrol alters lipid metabolism-related gene expression of mice on an atherogenic diet. Journal of Hepatology 2008, 49:1019-1028.
2. Abdullah M.M., Riediger N.N., Chen Q., Zhao Z., Azordegan N., Xu Z., Fischer G., Othman R.A., Pierce G.N., Tappia P.S., Zou J., Moghadasian M.H. Effect of long-term consumption of a high-fructose diet on conventional cardiovascular risk factors in Sprague Dawley rats. Molecular and Cellular Biochemistry 2009, 327:247-256.
3. Baur J.B., Pearson K.J., Price N.L., Jamieson H.M., Lerin C., Kalra A., Prabhu V.V., Allard J.S., Lopez-Lluch G., Lewis K., Pistell P.J., Poosala S., Becker K., Boss O., Gwinn D., Wang M., Ramaswamy S., Fishbein K.W., Spencer R.G., Lakatta E.G., Le Couter D., Shaw R.J., Navas P., Puigserver P., Ingram D., de Cabo R., Sinclair D.A. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 2006, 444:280-281.
4. Bray G.A., Nielsen S.J., Popkin B.M. Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. American Journal of Clinical Nutrition 2004, 79:865-875.
5. Bujanda L., Hijona E., Larzabal M., Beraza M., Aldazabal P., García-Urkia N., Sarasqueta C., Cosme A., Irastorza B., González A., Arenas J.I. Resveratrol inhibits nonalcoholic fatty liver disease in rats. BMC Gastroenterology 2008, 8:40-48.
6. Ciok J., Tacikowski T., Wyrobek I. Fruktoza jako czynnik ryzyka przewlekłych chorób metabolicznych (fructse as the risk factor of non-communicable chronic diseases). żywienie Człowieka i Metabolizm 2004, 1:88-95. (in Polish).
7. Chang C.-Y., Lee T.-S., Sheu W.H-H. Anti-atherogenic effect of resveratrol via liver X receptor α-dependent upregulation of ATP-binding cassette transporters A1 and G1 in macrophages. Journal of Functional Foods 2012, 4:727-735.
8. Deng J.Y., Hsieh P.-S., Huang J.-P., Lu L.S., Hung L.-M. Activation of estrogen receptor is crucial for resveratrol-stimulating muscular glucose uptake via both insulin-dependent and -independent pathways. Diabetes 2008, 57:1814-1823.
9. Fortuna, T., Juszczak, L., & Sobolewska-Zielińska, J. (2003). Podstawy analizy żywnoŚci. Basic of food analysis Wydawnictwo Akademii Rolniczej w Krakowie (in Polish).
10. Friedewald W.T., Fredrick D.S., Levy R.I. Estimation of concentration of low-density lipoprotein cholesterol in plasma, without use of preparative ultracentrifuge. Clinical Chemistry 1972, 18:499-502.
11. Haring S.J., Harris R.B. The relation between dietary fructose, dietary fat and leptin responsiveness in rats. Physiology & Behavior 2011, 104:914-922.
12. Hallfrisch J. Metabolic effect of dietary fructose. FASEB Journal 1990, 4:2652-2660.
13. Juan M.E., Vinardell M.P., Planas J.M. The daily oral administration of high doses of trans-resveratrol to rats for 28days is not harmful. Journal of Nutrition 2002, 132:257-260.
14. Kasdallah-Grissa A., Mornagui B., Aouani E., Hammami M., Gharbi N., Kamoun A., El-Fazaa S. Protective effect of resveratrol on ethanol-induced lipid peroxidation in rats. Alcohol and Alcoholism 2006, 41:236-239.
15. Kim S., Jin Y., Choi Y., Park T. Resveratrol exerts anti-obesity effects via mechanisms involving down-regulation of adipogenic and inflammatory processes in mice. Biochemical Pharmacology 2011, 81:1343-1351.
16. Kiernan, J. A. (1990). Histological & histochemical methods theory & practice (2nd ed., pp. 413-421). Great Britain BPCC: Pergamon Press, Wheatons Ltd., Exeter.
17. Labbé A., Garand C., Cogger V.C., Paguet E.R., Desbiens M., Le Couteur D.G., Lebel M. Resveratrol improves insulin resistance hyperglycemia and hepatosteatosis but not hypertriglyceridemia, inflammation, and life span in a mouse model for Werner syndrome. Journals of Gerontology 2011, 66:264-278.
18. Leiro J.M., Varela M., Piazzon M.C., Arranz J.A., Noya M., Lamas J. The anti-inflammatory activity of the polyphenol resveratrol may be partially related to inhibition of tumor necrosis factor-alpha (TNF-α) pre-mRNA splicing. Molecular Immunology 2010, 47:1114-1120.
19. Miatello R., Vázquez M., Renna N., Cruzado M., Zumino A.P., Risler N. Chronic administration of resveratrol prevents biochemical cardiovascular changes in fructose-fed rats. American Journal of Hypertension 2005, 18:864-870.
20. Miura D., Miura Y., Nagasaki K. Hypolipidemic action of dietary resveratrol, a phytoalexin in grapes and red wine, in hepatoma-bearing rats. Life Sciences 2003, 73:1393-1400.
21. Palsamy P., Subramanian S. Resveratrol, a natural phytoalexin, normalizes hyperglycemia in strepotzotocin-nicotinamide induced experimental diabetic rats. Biomedicine & Pharmacotherapy 2008, 62:598-605.
22. Palsamy P., Subramanian S. Resveratrol protects diabetic kidney by attenuating hyperglycemia-mediated oxidative stress and renal inflammatory cytokines via Nrf2-Keap1 signaling. Biochimica et Biophysica Acta 2011, 1812:719-731.
23. Pervaiz S. Resveratol: From grapevines to mammalian biology. FASEB Journal 2003, 17:1975-1985.
24. Rayalam S., Della-Fera M.A., Baile C.A. Synergism between resveratrol and other phytochemicals: Implications for obesity and osteoporosis. Molecular Nutrition and Food Research 2011, 55:1177-1185.
25. Reeves P.G. Components of the AIN-93 diets as improvements in the AIN-76A diet. Journal of Nutrition 1997, 127:838-841.
26. Rivera L., Morón R., Zarzuelo A., Galisteo M. Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats. Biochemical Pharmacology 2009, 6:1053-1063.
27. Romero-Sarmiento Y., Soto-Rodríguez I., Arzaba-Villalba A., García H.S., Alexander-Aguilera A. Effects of conjugated linoleic acid on oxidative stress in rats with sucrose-induced non-alcoholic fatty liver disease. Journal of Functional Foods 2012, 4:219-225.
28. Silan C. The effect of chronic resveratrol treatment on vascular responsiveness of streptozotocin-induced diabetic rats. Biological & Pharmaceutical Bulletin 2008, 31:897-902.
29. Su H., Hung L., Chen J. Resveratrol, a red wine antioxidant, possesses an insulin-like effect in streptozotocin-induced diabetic rats. American Journal of Physiology, Endocrinology and Metabolism 2006, 290:1339-1346.
30. Szkudelska K., Nogowski L., Szkudelski T. Resveratol a naturally occurring diphenolic compound, affect lipogenesis, lipolysis and the antilipolytic action of insulin in isolated rat adypocytes. Journal of Steroid Biochemistry and Molecular Biology 2009, 113:17-24.
31. Schmatz R., Perreira L.B., Stefanello N., Mazzanti C., Spanevello R., Gutierres J., Bagatini M., Martins C.C., Abdalla F.H., da Silva Daci, Serres J.D., Zanini D., Vieira J.M., Cardoso A.M., Schetinger M.R., Morsch M. Effect of resveratrol on biomarkers of oxidative stress and on the activity of delta aminolevulinic acid dehydratase in liver and kidney of streptozotocin-induced diabetic rats. Biochime 2012, 94:374-383.
32. Toklu H.Z., Sehirli O., Erşahin M., Süleymanoĝlu S., Yiĝiner O., Emekli-Alturfan E., Yarat A., Yeĝen B.Ç., Sener G. Resveratrol improves cardiovascular function and reduces oxidative organ damage in the renal, cardiovascular and cerebral tissues of two-kidney, one-clip hypertensive rats. The Journal of Pharmacy and Pharmacology 2010, 62:1784-1793.